Cancer
Cancer Research: ‘Advert helped early diagnosis’
December 10, 2013Medical Communications, Sales and Marketing Cancer, be clear, cough, government
A TV campaign urging people with a persistent cough to visit their doctor has led to hundreds of people receiving …
GSK launches cancer ‘consortium’
December 6, 2013Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research
GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
Astellas seeks Xtandi extension
December 5, 2013Sales and Marketing Astellas, Cancer, EU, FDA, US, Xtandi
Astellas Pharma and development partner Medivation are seeking to extend the reach of oncology brand Xtandi by conducting a trial …
Celgene signs $177 million OncoMed deal
December 4, 2013Research and Development, Sales and Marketing Cancer, Celgene, OncoMed, stem cell
Celgene Corporation is paying OncoMed Pharmaceuticals $177.25 million to get access to its pipeline as part of a deal to …
Third failure for Sanofi/Merrimack cancer drug
November 27, 2013Research and Development, Sales and Marketing Cancer, Sanofi, merrimack, mm-121
Sanofi and partner Merrimack have posted yet more disappointing results for their investigational cancer medicine MM-121. In the latest study …
US regulator shows Nexavar green light
November 25, 2013Sales and Marketing Bayer, Cancer, FDA, Nexavar, Onyx, thyroid
The FDA has extended the indication of liver and kidney cancer pill Nexavar to treat late-stage differentiated thyroid cancer. It …
Cancer Research UK invests £100m in research centres
November 25, 2013Research and Development, Sales and Marketing Cancer, Cancer Research UK, UK
Cancer Research UK says it will invest over £100 million across 15 cutting-edge research centres to help get new treatments …
Cancer app takes top prize in Janssen digital awards
November 22, 2013Medical Communications, Sales and Marketing Cancer, J&J, JJ, app, digital, px healthcare
A start-up firm established by medical scientists that develops mobile apps for cancer patients has taken first place in the …
Scientists map cancer ‘family tree’
November 18, 2013Research and Development, Sales and Marketing Cancer, DNA, ICR, family tree
A method to take the DNA fingerprint of individual cancer cells is uncovering the true extent of cancer’s genetic diversity …
Roche signs $17 million immatics deal
November 15, 2013Research and Development, Sales and Marketing Cancer, Roche, immatics, lung, prostate
Roche is to pay German biotech company immatics $17 million to collaborate on the search for vaccines in various cancers, …
Dendreon slashes more jobs
November 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing Cancer, Dendreon, Provenge, cuts
Another 150 jobs are to go at Dendreon Corporation as the company seeks to cut $125 million per year in …
AstraZeneca ups cancer drug production at Alderley Park
November 11, 2013Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Zoladex, alderley park
AstraZeneca says it plans to invest around £120 million in a new cancer drug manufacturing facility at its plant in …
Cancer Research backs ‘unique’ database
November 11, 2013Research and Development, Sales and Marketing Cancer, Database, ICR, cansar
An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …
The CDF: friend and foe?
November 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low
Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …
ImmunoGen stops cancer trial
November 6, 2013Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche
Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
